Development of a tau hyperphosphorylation assay in CDKL5 deficiency disorder iPSC-derived neurons

Awardee: Jedd Hubbs, PhD

Institution: Boston Children's Hospital, USA

Award Amount: $149,050

Funding Period: May 1, 2025 - April 31, 2026

Previous
Previous

Regulation of CDKL5 Function by Type I Interferons"

Next
Next

Exploiting microRNAs to disclose novel pathophysiological mechanisms, biomarkers and therapeutic approaches for CDKL5 deficiency disorder